Witnesses: Francis Collins, Director, Nat. Human Genome Research Inst., Nat. Inst. of Health (NIH); Gary Claxton, Deputy Assistant Secretary for Planning and Evaluation, U.S. Dept. of Health and Human Services (HHS); Christine Brunswick, Nat. Breast Cancer Coalition; Judith Palkovitz, Hadassah; Jodi Rucquoi, Dept. of Genetics, Yale Univ. School of Med.; Joanne Denise, Nat. Assoc. of Health Underwriters; Jack Ehnes, commissioner of insur., State of Colorado, for the Nat. Assoc. of Insur. Commissioners; and Mary Lehnhard, Blue Cross/Blue Shield Association. Also, prepared statement by the Health Insur. Assoc. of America.

It is difficult to think of an example of an advancement in the biological sciences that has had an impact on society similar to that of the new genetics. Recent developments in biotechnology have occasioned much discussion among academics, professionals, and lay people alike. In particular, many questions and concerns have arisen over the acquisi tion, access, and control of genetic information. There are several reasons why the new genetics has commanded such widespread attention, and why it is now the subject of con siderable debate. Special reference is given in this volume to the implications of genetic information for five different subject areas: eugenics, the insurance industry, the commer cialisation of genetic testing, strategies for raising public awareness, and the value of theo retical ethical and sociological frameworks in the debate. This diverse collection of papers attempts to address and critically discuss issues surrounding the control of, and access to, genetic information from ethical, medical, legal, and theoretical points of view. The first and shortest section of the book attempts to address concerns over the eugenic potential of new biotechnologies. It also provides a historical context for the de bate, for controversy over the subject of eugenics predates the current debate over genetic information by a considerable length of time. Indeed, by the time the first patent was is sued for Chakrabarty's strain of oil eating bacteria in the early 1970s, the term eugenics had already acquired strong pejorative connotations.

The genetic era has given rise to significant legal dilemmas: who may own genetic data, when can a genetic test be performed on children, how can genetic-based discrimination be avoided, or to what extent and in what ways can genetic data be protected? The book addresses the social, ethical, and legal implications of collecting, storing, analyzing, and commercializing genetic information. Prominent biologists, medical doctors, lawyers, anthropologists, philosophers, sociologists, and theologians from different countries provide their views on the complex biological and social impacts of the imminent proliferation of genetic information. The authors explore the various uses and applications of genetic information, and discuss the current dilemmas of making laws in the field of genetics. Different models of national genome projects and biobanks, as well as the related international legal documents and national laws are also discussed. Various genome projects and biobanks are analyzed in detail.

This volume relates to the first stage of the PRIVIREAL project regarding the implementation of the Data Protection Directive. It includes keynote papers addressing specific questions on the subject, and a report on both the general implementation of the Directive and the implementation in relation to medical research.

For too long now, the issue of health care reform has been dominated by the techniques of mainstream economics and the constant application of the tools of cost-benefit analysis to an area that does not suit it.Issues such as privacy, genetic testing and the allocation of organ transplants require a more sensitive approach to the setting of budgets

"Digital Transformation in Healthcare 5.0: IoT, AI, and Digital Twin" provides a comprehensive overview of the integration of cutting-edge technology with healthcare, from the Fourth Industrial Revolution (4IR) to the introduction of IoT, AI, and Digital Twin technologies. This in-depth discussion of the digital revolution expanding the healthcare industry covers a wide range of topics, including digital disruption in healthcare delivery, the impact of 4IR and Health 4.0, e-health services and applications, virtual reality's impact on accessible healthcare delivery, digital twins and dietary health technologies, big data analytics in healthcare systems, machine learning models for cost-effective healthcare delivery systems, affordable healthcare with machine learning, enhanced biomedical signal processing with machine learning, and data-driven AI for information retrieval of biomedical images.